These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23466816)

  • 1. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
    Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
    BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
    Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
    Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
    Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.
    Llanos AA; Krok JL; Peng J; Pennell ML; Vitolins MZ; Degraffinreid CR; Paskett ED
    Horm Cancer; 2014 Apr; 5(2):98-103. PubMed ID: 24435584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.
    White DL; Hoogeveen RC; Chen L; Richardson P; Ravishankar M; Shah P; Tinker L; Rohan T; Whitsel EA; El-Serag HB; Jiao L
    Cancer Med; 2018 May; 7(5):2180-2191. PubMed ID: 29573228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.
    Macis D; Bellerba F; Aristarco V; Johansson H; Guerrieri-Gonzaga A; Lazzeroni M; Sestak I; Cuzick J; DeCensi A; Bonanni B; Gandini S
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial.
    Llanos AA; Peng J; Pennell ML; Krok JL; Vitolins MZ; Degraffinreid CR; Paskett ED
    J Clin Endocrinol Metab; 2014 Feb; 99(2):625-32. PubMed ID: 24423335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
    Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
    Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
    Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.
    Catsburg C; Gunter MJ; Chen C; Cote ML; Kabat GC; Nassir R; Tinker L; Wactawski-Wende J; Page DL; Rohan TE
    Cancer Res; 2014 Jun; 74(12):3248-58. PubMed ID: 24755474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.
    Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
    Am J Epidemiol; 2013 Jan; 177(1):3-13. PubMed ID: 23171880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
    Ermakov S; Azarbal F; Stefanick ML; LaMonte MJ; Li W; Tharp KM; Martin LW; Nassir R; Salmoirago-Blotcher E; Albert CM; Manson JE; Assimes TL; Hlatky MA; Larson JC; Perez MV
    Heart; 2016 Sep; 102(17):1354-62. PubMed ID: 27146694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
    Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
    Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.